Skip to main content
Top
Published in: Acta Diabetologica 1/2010

01-12-2010 | Original Article

The oxidative stress status in diabetes mellitus and diabetic nephropathy

Authors: Hong-zhi Pan, Lin Zhang, Mei-yi Guo, Hong Sui, Hui Li, Wei-hua Wu, Nai-qiang Qu, Mei-hua Liang, Dong Chang

Published in: Acta Diabetologica | Special Issue 1/2010

Login to get access

Abstract

The aim of this study is to assess the oxidative stress status in diabetes mellitus (DM) and diabetic nephropathy. The study group comprised 40 control subjects, 40 type 2 DM patients without complications and 37 diabetic nephropathies. Compared with control subjects, superoxide dismutase, glutathione peroxidase, catalase, vitamin C were decreased (P < 0.01). There was a significant increase in serum malondialdehyde (MDA), conjugated diene (CD), advanced oxidation protein products (AOPP), protein carbonyl (PC) and 8-hydroxy-2′-deoxyguanosine (8-OHdG) in diabetes patients when compared with normal subjects (P < 0.01). Moreover, these indexes were much higher in diabetic nephropathy than that of diabetic patients without vascular complications (P < 0.05, P < 0.01). There was a significant correlation between the serum glucose levels and PC, 8-OHdG (P < 0.05, P < 0.01). There were highly significant positive correlation of CD and MDA, AOPP and PC (P < 0.01). Plasma AOPP levels had a significant correlation with PC levels (P < 0.01). Our findings suggested that diabetes patients have more severe oxidative stress than normal persons and higher oxidative stress in diabetic nephropathy than those in patients without complications. Oxidative stress may play an important intermediary role in the pathogenesis of diabetes complications.
Literature
1.
go back to reference Rathmann W, Giani G (2004) Global prevalence of diabetes: estimates for the year 2000, projections for 2030. Diabetes Care 27(10):2568–2569CrossRefPubMed Rathmann W, Giani G (2004) Global prevalence of diabetes: estimates for the year 2000, projections for 2030. Diabetes Care 27(10):2568–2569CrossRefPubMed
2.
go back to reference Giugliano D, Ceriello A (1996) Oxidative stress and diabetic vascular complications. Diabetes care 19(3):257–267CrossRefPubMed Giugliano D, Ceriello A (1996) Oxidative stress and diabetic vascular complications. Diabetes care 19(3):257–267CrossRefPubMed
3.
go back to reference Mehrotra S, Ling KL, Bekele Y, Gerbino E, Earle KA (2001) Lipid hydroperoxide and markers of renal disease susceptibility in African–Caribbean and Caucasian patients with Type 2 diabetes mellitus. Diabet Med 18:109–115CrossRefPubMed Mehrotra S, Ling KL, Bekele Y, Gerbino E, Earle KA (2001) Lipid hydroperoxide and markers of renal disease susceptibility in African–Caribbean and Caucasian patients with Type 2 diabetes mellitus. Diabet Med 18:109–115CrossRefPubMed
4.
go back to reference Calabrese V, Mancuso C, Sapienza M et al (2007) Oxidative stress and cellular stress response in diabetic nephropathy. Cell Stress Chaperones 12:299–306CrossRefPubMed Calabrese V, Mancuso C, Sapienza M et al (2007) Oxidative stress and cellular stress response in diabetic nephropathy. Cell Stress Chaperones 12:299–306CrossRefPubMed
5.
go back to reference Kikkawa R, Koya D, Haneda M (2003) Progression of diabetic nephropathy. Am J Kidney Dis 41:S19–S21CrossRefPubMed Kikkawa R, Koya D, Haneda M (2003) Progression of diabetic nephropathy. Am J Kidney Dis 41:S19–S21CrossRefPubMed
6.
go back to reference Suzuki S, Hinokio Y, Komatu K et al (1999) Oxidative damage to mitochondrial DNA and its relationship to diabetic complications. Diabetes Res Clin Pract 45:161–168CrossRefPubMed Suzuki S, Hinokio Y, Komatu K et al (1999) Oxidative damage to mitochondrial DNA and its relationship to diabetic complications. Diabetes Res Clin Pract 45:161–168CrossRefPubMed
7.
go back to reference Ward PA, Till GO, Hatherill JR, Annesley TM, Kunkel RG (1985) Systemic complement activation, lung injury, and products of lipid peroxidation. J Clin Invest 76:517–527CrossRefPubMed Ward PA, Till GO, Hatherill JR, Annesley TM, Kunkel RG (1985) Systemic complement activation, lung injury, and products of lipid peroxidation. J Clin Invest 76:517–527CrossRefPubMed
8.
go back to reference Witko-Sarsat V, Friedlander M, Capeillère-Blandin C et al (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–1313CrossRefPubMed Witko-Sarsat V, Friedlander M, Capeillère-Blandin C et al (1996) Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–1313CrossRefPubMed
9.
go back to reference Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1–9CrossRefPubMed Baynes JW, Thorpe SR (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48:1–9CrossRefPubMed
10.
go back to reference Signorello MG, Viviani GL, Armani U et al (2007) Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus. Thromb Res 120:607–613CrossRefPubMed Signorello MG, Viviani GL, Armani U et al (2007) Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus. Thromb Res 120:607–613CrossRefPubMed
11.
go back to reference Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR (1996) Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 4:255–260 Sundaram RK, Bhaskar A, Vijayalingam S, Viswanathan M, Mohan R, Shanmugasundaram KR (1996) Antioxidant status and lipid peroxidation in type II diabetes mellitus with and without complications. Clin Sci (Lond) 4:255–260
12.
go back to reference Bhatia S, Shukla R, Venkata Madhu S, Kaur Gambhir J, Madhava Prabhu K (2003) Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 36:557–562CrossRefPubMed Bhatia S, Shukla R, Venkata Madhu S, Kaur Gambhir J, Madhava Prabhu K (2003) Antioxidant status, lipid peroxidation and nitric oxide end products in patients of type 2 diabetes mellitus with nephropathy. Clin Biochem 36:557–562CrossRefPubMed
13.
go back to reference Kedziora-Kornatowska KZ, Luciak M, Blaszczyk J, Pawlak W (1998) Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy. Nephrol Dial Transpl 13:2829–2832CrossRef Kedziora-Kornatowska KZ, Luciak M, Blaszczyk J, Pawlak W (1998) Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with non-insulin dependent diabetes with or without diabetic nephropathy. Nephrol Dial Transpl 13:2829–2832CrossRef
14.
go back to reference Pan HZ, Zhang H, Chang D, Li H, Sui H (2008) The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 92:548–551CrossRefPubMed Pan HZ, Zhang H, Chang D, Li H, Sui H (2008) The change of oxidative stress products in diabetes mellitus and diabetic retinopathy. Br J Ophthalmol 92:548–551CrossRefPubMed
15.
go back to reference Dursun E, Timur M, Dursun B, Süleymanlar G, Ozben T (2005) Protein oxidation in Type 2 diabetic patients on hemodialysis. J Diabetes Complicat 19:142–146CrossRefPubMed Dursun E, Timur M, Dursun B, Süleymanlar G, Ozben T (2005) Protein oxidation in Type 2 diabetic patients on hemodialysis. J Diabetes Complicat 19:142–146CrossRefPubMed
16.
go back to reference Kalousová M, Skrha J, Zima T (2002) Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 51:597–604PubMed Kalousová M, Skrha J, Zima T (2002) Advanced glycation end-products and advanced oxidation protein products in patients with diabetes mellitus. Physiol Res 51:597–604PubMed
17.
go back to reference Witko-Sarsat V, Friedlander M, Nguyen Khoa T et al (1998) Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161:2524–2532PubMed Witko-Sarsat V, Friedlander M, Nguyen Khoa T et al (1998) Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 161:2524–2532PubMed
18.
go back to reference Cakatay U (2005) Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 31:551–557CrossRefPubMed Cakatay U (2005) Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab 31:551–557CrossRefPubMed
19.
go back to reference Ramakrishna V, Jailkhani R (2007) Evaluation of oxidative stress in Insulin Dependent Diabetes Mellitus (IDDM) patients. Diagn Pathol 2:22CrossRefPubMed Ramakrishna V, Jailkhani R (2007) Evaluation of oxidative stress in Insulin Dependent Diabetes Mellitus (IDDM) patients. Diagn Pathol 2:22CrossRefPubMed
20.
go back to reference Piwowar A, Knapik-Kordecka M, Szczecińska J, Warwas M (2008) Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy. Diabetes Metab Res Rev 24:549–553CrossRefPubMed Piwowar A, Knapik-Kordecka M, Szczecińska J, Warwas M (2008) Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy. Diabetes Metab Res Rev 24:549–553CrossRefPubMed
21.
go back to reference Wu LL, Chiou CC, Chang PY, Wu JT (2004) Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 339:1–9CrossRefPubMed Wu LL, Chiou CC, Chang PY, Wu JT (2004) Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 339:1–9CrossRefPubMed
22.
go back to reference Dandona P, Thusu K, Cook S et al (1996) Oxidative damage to DNA in diabetes mellitus. Lancet 347:444–445CrossRefPubMed Dandona P, Thusu K, Cook S et al (1996) Oxidative damage to DNA in diabetes mellitus. Lancet 347:444–445CrossRefPubMed
23.
go back to reference Leinonen J, Lehtimäki T, Toyokuni S et al (1997) New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 417:150–152CrossRefPubMed Leinonen J, Lehtimäki T, Toyokuni S et al (1997) New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 417:150–152CrossRefPubMed
24.
go back to reference Kanauchi M, Nishioka H, Hashimoto T (2002) Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron 91:327–329CrossRefPubMed Kanauchi M, Nishioka H, Hashimoto T (2002) Oxidative DNA damage and tubulointerstitial injury in diabetic nephropathy. Nephron 91:327–329CrossRefPubMed
25.
go back to reference Kaneto H, Fujii J, Suzuki K et al (1994) DNA cleavage induced by glycation of Cu, Zn superoxide dismutase. Biochem J 304(pt1):219–225PubMed Kaneto H, Fujii J, Suzuki K et al (1994) DNA cleavage induced by glycation of Cu, Zn superoxide dismutase. Biochem J 304(pt1):219–225PubMed
Metadata
Title
The oxidative stress status in diabetes mellitus and diabetic nephropathy
Authors
Hong-zhi Pan
Lin Zhang
Mei-yi Guo
Hong Sui
Hui Li
Wei-hua Wu
Nai-qiang Qu
Mei-hua Liang
Dong Chang
Publication date
01-12-2010
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue Special Issue 1/2010
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-009-0128-1

Other articles of this Special Issue 1/2010

Acta Diabetologica 1/2010 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.